NexoBrid
·
- Prescription status not stated
- Skin
- Active substance
- Concentrate of proteolytic enzymes enriched in bromelain
- Used in
- Skin
- Made by
- MediWound Germany GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- NexoBrid is indicated in all age groups for removal of eschar in patients with deep partial- and full-thickness thermal burns.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | MediWound Germany GmbH |
|---|---|
| Active substance | Concentrate of proteolytic enzymes enriched in bromelain |
| Used in | Skin |
| Classification | D03BA03 · Skin |
| Authorised on | 2012-12-18 |
| Last updated by the regulator | 2025-12-03 |
| EMA product number | EMEA/H/C/002246 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).